MarginsXMarginsX
Home › Canada › CSE stocks › CL

Cresco Labs Inc. (CSE: CL)

CL trades on the Canadian Securities Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.7200
+4.35% on the day
Market cap (C$)
C$362.0M
TMX list, November 13, 2026
Market cap (US$)
US$253.9M
Micro cap at 1.4257 C$/US$
1-year return
-52.0%
-56.6% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for CL.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 40-F text ("our website").

Profile

FieldValue
TickerCL on the Canadian Securities Exchange
Yahoo symbolCL.CN
SectorLife Sciences, Drug Manufacturers—Specialty & Generic
HeadquartersBritish Columbia
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstanding502,755,064
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0001832928
Websitewww.crescolabs.com

Returns

WindowReturn
1 day+4.3%
1 week-8.9%
1 month-20.0%
3 months-34.5%
6 months-43.3%
Year to date-56.6%
1 year-52.0%
From 52-week high-73.5%
52-week rangeC$0.6900 to C$2.72

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

69 documents in 11 types. Each title links to the document at its source.

Annual financial statements (2)

Interim financial statements (9)

MD&A (9)

Annual information form (2)

DocumentTypeFiled
Annual Information Form of the Company for the year ended December 31, 2025
Period 2025-12-31
Annual information form (40-F)2026-03-06
Annual Information Form of the Company for the year ended December 31, 2024
Period 2024-12-31
Annual information form (40-F)2025-03-14

News release (14)

DocumentTypeFiled
News Release dated November 6, 2026News release (6-K)2026-11-06
News Release dated November 2, 2026News release (6-K)2026-11-03
News Release dated August 6, 2026News release (6-K)2026-08-06
News Release dated May 8, 2026News release (6-K)2026-05-08

Management information circular / proxy (9)

Prospectus (2)

DocumentTypeFiled
F-10Prospectus (short form) (F-10)2025-10-06
Prospectus Supplement dated January 29, 2026Prospectus supplement (6-K)2026-02-02

Annual report (2)

DocumentTypeFiled
40-F
Period 2025-12-31
Annual report (40-F) (40-F)2026-03-06
40-F
Period 2024-12-31
Annual report (40-F) (40-F)2025-03-14

Early warning / ownership (3)

DocumentTypeFiled
Schedule 13G amendmentSchedule 13G (SCHEDULE 13G/A)2025-05-15
Schedule 13GSchedule 13G (SCHEDULE 13G)2025-02-14
Schedule 13G amendmentSchedule 13G (SC 13G/A)2024-11-14

Certification (6)

Other (11)

DocumentTypeFiled
Consent of Marcum LLP
Period 2025-12-31
Consent (40-F)2026-03-06
Consent of Baker Tilly, LLP
Period 2025-12-31
Consent (40-F)2026-03-06
EX-5.1Consent (F-10)2025-10-06
EX-5.2Consent (F-10)2025-10-06

Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

Trading: the last notice, on 2025-12-18, was a resumption.

NoticeActionReasonNotice
2025-12-18 1:07:03 PM ETResumptionNo reason statedCIRO notice
2025-12-18 1:02:03 pm ETHaltSingle Stock Circuit BreakerCIRO notice
2025-10-15 12:53:39 PM ETResumptionNo reason statedCIRO notice
2025-10-15 12:48:39 PM ETHaltSingle Stock Circuit BreakerCIRO notice
2025-08-29 10:02:47 AM ETResumptionNo reason statedCIRO notice
2025-08-29 9:57:47 AM ETHaltSingle Stock Circuit BreakerCIRO notice

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Recent

DateTimeEventWebcastSource
2026-11-06No time in the announcementQ3 2026 earnings releaseNo webcast link announcedSEC filing
2026-11-068:30am Eastern TimeQ3 2026 earnings callWebcastSEC filing

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2021-12-21EquityUS$62.1MUS$62.1MSEC EDGAR
2018-10-23EquityUS$100.0MUS$100.0MSEC EDGAR
2018-10-19EquityUS$100.0MUS$100.0MSEC EDGAR
2014-10-06EquityUS$4.0MUS$4.0MSEC EDGAR

Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
ACBAurora Cannabis Inc.TSXC$372.0M+15.4%+14.4%
PRNProfound Medical Corp.TSXC$335.6M+6.1%+17.3%
WEEDCanopy Growth CorporationTSXC$393.7M-25.0%-47.1%
CPHCipher Pharmaceuticals Inc.TSXC$329.3M+5.0%+6.6%
PAINVector Science and Therapeutics Corp.TSXVC$309.8M+75.2%Under a year of closes

The app has the price chart, every filing, private raises and the full peer set for CL.

Open in the app